Organometallics
Organometallic compounds are those that contain bonds between carbon atoms and metals, usually transition metals such as magnesium, zinc, or platinum. These compounds exhibit a wide structural and chemical diversity, giving them high reactivity. They are mainly used in organic synthesis, catalysing reactions such as monomer polymerisation and carbon-carbon bond formation. Additionally, organometallic compounds have applications in the pharmaceutical industry, including the manufacture of anticancer drugs, as well as in industrial processes such as plastic and fuel production.
At CymitQuimica, we offer a wide range of organometallic compounds for research in organic chemistry, catalysis, and the synthesis of new materials.
Found 4400 products of "Organometallics"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Bismuth Potassium Citrate-d8 (Bismuth Subcitrate-d8)
CAS:Formula:C6H4D4O7·Bi·3KMolecular weight:2*196.15 208.98 3*39.10DOTE (di-n-Octyltin bis(2-ethylhexyl) mercaptoacetate)-d4
CAS:Formula:C36H68O4S2SnD4Molecular weight:755.81BISMUTH SUBGALLATE
CAS:<p>Bismuth subgallate (Dermatol Puder) is an astringent and antiseptic and is applied to skin diseases such as eczema.</p>Formula:C7H5BiO6Purity:98.7%Color and Shape:White To Yellow CrystalsMolecular weight:394.09Lobaplatin
CAS:<p>Lobaplatin (D-19466) (D-19466) is a diastereometric mixture of platinum(II) complexe.</p>Formula:C9H18N2O3PtPurity:98.00%Color and Shape:SolidMolecular weight:397.33Iron sucrose
CAS:<p>Iron sucrose (Sucroferric oxyhydroxide) is treatment of iron deficiency anemia.</p>Formula:C18H24Fe2O24Purity:99.97%Color and Shape:SolidMolecular weight:736.1Ferrous Bisglycinate
CAS:<p>Ferrous Bisglycinate (Bisglycine iron(II) salt) is used in the fortification of infant formulations and foods.</p>Formula:C4H8FeN2O4Purity:≥95%Color and Shape:SolidMolecular weight:203.96Gadodiamide
CAS:<p>Gadodiamide is an MRI contrast agent, used in MR imaging procedures to assist in the visualization of blood vessels.</p>Formula:C16H26GdN5O8Purity:99.86%Color and Shape:SolidMolecular weight:573.66VLX600
CAS:<p>VLX600 is an iron-chelating oxidative phosphorylation (OXPHOS) inhibitor, is a cell-permeable anticancer agent.</p>Formula:C17H15N7Purity:98.62%Color and Shape:SolidMolecular weight:317.35NU6027
CAS:<p>NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 μM/1.3 μM, 0.4 μM and 2.2 μM, enter cells more readily than the 6-</p>Formula:C11H17N5O2Purity:98.36%Color and Shape:SolidMolecular weight:251.29Eurycomalactone
CAS:<p>Eurycomalactone, from Eurycoma longifolia, inhibits NF-κB (IC50 0.5 μM), stops protein synthesis and cyclin D1, spares IκBα and IKK.</p>Formula:C19H24O6Purity:99.48% - 99.87%Color and Shape:SolidMolecular weight:348.39Iohexol
CAS:Controlled Product<p>Applications Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H26I3N3O9Color and Shape:Off-WhiteMolecular weight:821.14(2-Butoxy-4-fluorophenyl)boronic acid
CAS:Formula:C10H14BFO3Purity:95.0%Color and Shape:SolidMolecular weight:212.03DOTA
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Bifunctional DOTA conjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and therapeutic radiopharmaceuticals.<br>References Lewis, M., et al.: Bioconjug. Chem., 9, 72 (1998), Chappell, L., et al.: Bioorg. Med. Chem., 7, 2313 (1999), Prantner, A., et al.: Mol. Imaging, 2, 333 (2003), Allen, M., et al.: Chem. Biol., 11, 301 (2004), Weiner, R., et al.: BioDrugs, 19, 145 (2005), Breeman, W., et al.: Radionuclide Peptide Cancer Therapy, 119 (2006),<br></p>Formula:C16H28N4O8Color and Shape:Light YellowMolecular weight:404.42Iohexol-D5
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Deuterated Iohexol. Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C19H21D5I3N3O9Color and Shape:NeatMolecular weight:826.17(2-Ethoxy-4-methylpyridin-3-yl)boronic acid
CAS:Purity:95+%Color and Shape:SolidMolecular weight:181.0Gadodiamide
CAS:Controlled Product<p>Applications Gadodiamide is an apoptosis inducing agent used in chondrocytes. It is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001);<br></p>Formula:C16H26GdN5O8Color and Shape:NeatMolecular weight:573.66(4-Chloro-2-propoxyphenyl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:214.4499969482422N-Acetyl Cyclized Iodixanol
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications N-Acetyl Cyclized Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C35H43I5N6O15Color and Shape:NeatMolecular weight:1422.27N1-(3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl) Iohexol
CAS:Controlled Product<p>Impurity Iohexol EP Impurity D<br>Applications N1-(3-(2,3-dihydroxypropoxy)-2-hydroxypropyl) Iohexol is an impurity of Iohexol (I729500), Imaging agent.<br>References Wolf, G.L., et al.: Invest. Radiol., 16, 320 (1981), Mancini, G.B.J., et al.: Am. J. Cardiol., 51, 1218 (1983), Bettmann, M.A., et al.: Radiology, 153, 583 (1984), Sullivan, I.D., et al.: Br. Heart J.,51, 643 (1984),<br></p>Formula:C22H32I3N3O11Color and Shape:Off-WhiteMolecular weight:895.22(3-Methoxypyridin-4-yl)boronic acid hydrate
CAS:Formula:C6H10BNO4Purity:95.0%Color and Shape:SolidMolecular weight:170.96(4-((2-Isopropyl-5-methylphenoxy)methyl)phenyl)boronic acid
CAS:Purity:96%Molecular weight:284.160003662109413-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid
CAS:<p>Applications 13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid is an impurity in the synthesis of Gadoteridol, an MRI contrast chelating agent.<br>References Petersein, J. et al.: Am. J. Roentgenol., 165, 1167 (1995);<br></p>Formula:C13H22N4O5Color and Shape:White SolidMolecular weight:314.34N,N’-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Impurity Iohexol USP Related Compound C<br>Applications N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide is used in the preparation of X-ray contrast agents.<br>References Haavaldsen, J. et al.: Acta Pharmac. Sue., 20, 219 (1983);<br></p>Formula:C14H19N3O8Color and Shape:White To Off-WhiteMolecular weight:357.32[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum
CAS:<p>Applications [SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN')diiodoplatinum is a potential antitumor agent. Impurity of Oxiplatin (O845075), third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y. et al.: Biomed. Pharmacther., 43, 261 (1989); Noji, M. et al.: J. Med. Chem., 24, 508 (1981); Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C6H14I2N2PtColor and Shape:NeatMolecular weight:563.08Potassium Trichloroammineplatinate
CAS:Controlled Product<p>Applications Potassium Trichloroammineplatinate is the degradation product of Cisplatin (C499500), an antitumor compound which exhibits mutagenic activity.<br>References Peer, R.L., et al.: Enivron. Mutagen., 3, 555 (1981); Macquet, J.P., et al.: Develop. Oncol., 17, 27 (1984); Macquet, J.P., et al.: J. Clin. Hematol. Oncol., 7, 469 (1997);<br></p>Formula:K·Cl3H3NPtColor and Shape:NeatMolecular weight:357.57Oxaliplatin-d10
CAS:Controlled Product<p>Applications Oxaliplatin-d10, is the labeled analogue of Oxaliplatin (O845075), which is platinum-based antineoplastic agent that is used in cancer chemotherapy.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H4D10N2O4PtColor and Shape:NeatMolecular weight:407.35Dihydroxy Oxaliplatin-Pt(IV)
CAS:Controlled Product<p>Applications An Oxaliplatin (O845075) derivative. An orally active antitumor cyclohexanediamine-Pt(IV) complex. Oxaliplatin impurity C as per EP.<br>References Yamashita, T., et al.: Biol. Pharma. Bull., 16, 1014 (1993),<br></p>Formula:C8H16N2O6PtColor and Shape:White To Light YellowMolecular weight:431.30Gadopentetic Acid
CAS:Controlled Product<p>Applications: Gadopentetic Acid is a magnetic resonance contrast agent being used to develop a new platform for the delivery of therapeutic and imaging agents simultaneously to the colon.<br>References Jin, M., et al.: Mol. Pharm, 13, 2457-2465 (2016)<br></p>Formula:C14H20GdN3O10Color and Shape:NeatMolecular weight:547.57Caldiamide Sodium
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Caldiamide Sodium is an analog of Gadodiamide (G125710) which is an apoptosis inducing agent used in chondrocytes. Gadodiamide is primarily used in muscoskeletal diagnosis as a contrast agent.<br>References Greisberg, J. et al.: Mag. Res. Imag., 19, 731 (2001); Hemmingsson, A. et al.: Mag. Res. Mat. Phys. Biol. Med., 12, 96 (2001)<br></p>Formula:C16H26CaN5NaO8Color and Shape:NeatMolecular weight:479.481,1-Cyclobutanedicarboxylic Acid
CAS:<p>Applications 1,1-Cyclobutanedicarboxylic Acid is used in the design, studies and structural model of antitumor dicycloplatin a clinical cancer drug. Hydrolysis mechanism of second-generation anticancer drug carboplatin.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Yang, X. Q., et al.: Science China: Chemistry, 53, 1346 (2010); Pavelka, M., et al.: Chem. Eur. J., 13, 10108 (2007)<br></p>Formula:C6H8O4Color and Shape:NeatMolecular weight:144.135-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An intermediate used in the synthesis of imaging agents such as Iohexol (I729500).<br>References Priebe, H., et al.: J. Clin. Pharm. Ther., 24, 227 (1999),<br></p>Formula:C16H20I3N3O7Color and Shape:NeatMolecular weight:747.06Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate
CAS:Controlled Product<p>Impurity Oxaliplatin EP Impurity E<br>Stability Light Sensitive<br>Applications A dimeric impurity of Oxaliplatin (O845075) with neoplasm-inhibiting activity.<br>References Gill, D.: Dev. Oncol., 17, 267 (1984);<br></p>Formula:C12H30N6O8Pt2Color and Shape:White To Light YellowMolecular weight:776.56Cyclic Iodixanol (90%)
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Cyclic Iodixanol is an impurity of Iodixanol (I667200) which is a nonionic, dimeric x-ray contrast medium.<br>References Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992), Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1993), Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1994)<br></p>Formula:C33H41I5N6O14Purity:90%Color and Shape:NeatMolecular weight:1380.23Des(2-Hydroxypropyl) Gadoteridol
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Des(2-hydroxypropyl) Gadoteridol is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent.<br>References Filippi, M. et al.: Chem. Comm., 50, 3453 (2014); Ferrauto, G. et al.: J. Am. Chem. Soc., 136, 638 (2014);<br></p>Formula:C14H23GdN4O6Color and Shape:NeatMolecular weight:500.61(2-(N-(tert-Butyl)sulfamoyl)phenyl)boronic acid
CAS:Formula:C10H16BNO4SPurity:98%Molecular weight:257.112-Fluoro-3-methoxyphenylboronic acid
CAS:Controlled Product<p>Applications 2-Fluoro-3-methoxyphenylboronic acid<br></p>Formula:C7H8BFO3Color and Shape:NeatMolecular weight:169.953-(Methoxycarbonyl)thiophene-2-boronic acid
CAS:Purity:95%Color and Shape:SolidMolecular weight:185.99000549316406Oxaliplatin
CAS:Controlled Product<p>Applications Third generation platinum complex. An antitumor agent with activity against colorectal cancer. Cytotoxicity follows the formation of adducts with DNA. Antineoplastic.<br>References Kidani, Y., et al.: J. Med. Chem., 21, 1315 (1978), Kizu, R., et al.: Cancer Chemother. Pharmacol., 31, 475 (1993), Levi, F., et al.: Eur. J. Cancer, 29A, 1280 (1993), Simpson, D., et al.: Drugs, 63, 2127 (2003),<br></p>Formula:C8H14N2O4PtColor and Shape:White To Off-WhiteMolecular weight:397.295-Amino-2,4,6-triiodoisophthalic Acid
CAS:Controlled Product<p>Impurity Iohexol EP Impurity K<br>Applications 5-Amino-2,4,6-triiodoisophthalic Acid (Iohexol EP Impurity K) is an intermediate for nonionic iodinated X-ray contrast agents.<br></p>Formula:C8H4I3NO4Color and Shape:NeatMolecular weight:558.84(4-(Diisopropylcarbamoyl)-2-ethoxypyridin-3-yl)boronic acid
CAS:Purity:95+%Molecular weight:294.16000366210943-Chloro-4-pyridineboronic acid hydrate
CAS:Formula:C5H7BClNO3Purity:95.0%Color and Shape:SolidMolecular weight:175.384-Borono-2,6-difluorobenzoic acid
CAS:Formula:C7H5BF2O4Purity:98%Color and Shape:No data available.Molecular weight:201.92(5,6-Difluoropyridin-3-yl)boronic acid
CAS:Formula:C5H4BF2NO2Purity:96%Color and Shape:No data available.Molecular weight:158.9(1-(Tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)boronic acid
CAS:Purity:98%Molecular weight:181.99000549316406(4-(Decyloxy)phenyl)boronic acid
CAS:Purity:97.0%Color and Shape:SolidMolecular weight:278.20001220703125(5-Cyano-1H-indol-2-yl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:185.97999572753906Gadoteric Acid
CAS:Controlled Product<p>Applications Gadoteric Acid is used for magnetic resonance imaging.<br>References Gheuens, E., et al.: Invest. Radiol., 49, 505-508 (2014)<br></p>Formula:C16H25GdN4O8Color and Shape:White To Off-WhiteMolecular weight:558.64(3-(Piperidin-1-yl)phenyl)boronic acid
CAS:Formula:C11H16BNO2Purity:97%Color and Shape:SolidMolecular weight:205.06(2-Fluoro-5-((4-methylpiperazin-1-yl)methyl)phenyl)boronic acid
CAS:Purity:98%Molecular weight:252.100006103515625-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Used as an intermediate in the industrial preparation of non-ionic X-ray contrast agents such as Iohexol (I729500), Ioversol (I737000), Ioxilan (I737500), Iopamidol (I735600).<br>References Rongved, P., et al.: Carbohydrate Res., 297, 325 (1997),<br></p>Formula:C14H18I3N3O6Color and Shape:NeatMolecular weight:705.02(1-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)-1H-indol-2-yl)boronic acid
CAS:Purity:95.0%Color and Shape:SolidMolecular weight:319.1199951171875Carboplatin
CAS:<p>Applications Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.<br>References Harland, S.J., et al.: Cancer Res., 44, 1693 (1984), Smith, I.E., et al.: Cancer Treat. Rep., 69, 43 (1985), Lygidakis, N.J., et al.: Interferon Cytokine Res., 15, 467 (1995),<br></p>Formula:C6H12N2O4PtColor and Shape:White To Off-WhiteMolecular weight:371.25(3-((4-Chlorophenoxy)methyl)phenyl)boronic acid
CAS:Formula:C13H12BClO3Purity:95.0%Color and Shape:SolidMolecular weight:262.5
![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FT283945.webp&w=3840&q=75)
![[SP-4-2-(1R-trans)]-(1,2-Cyclohexanediamine-κN,κN') Diiodoplatinum](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC984525.webp&w=3840&q=75)
![Diaquo[(1R,2R)-1,2-cyclohexanediamine]platinum Dimer Dinitrate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD416765.webp&w=3840&q=75)
